Takeda has ended development of its nausea and vomiting drug candidate for strategic reasons, continuing its multi-year ...
The New Dietary Guidelines for Americans 2025-2030 emphasize three goals: 1) Eat the right amount; 2) Prioritize protein at ...
Since Roche launched its long-acting eye disease medicine Vabysmo in 2022, Bayer and Regeneron have seen the impact on sales of their rival treatment Eylea, with the U.S. biotech taking a bigger hit.
The Global Asphalt Paving Material Market is witnessing sustained growth as governments, construction firms, and ...
Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio –– Extends ...
According to MarketsandMarkets™, the AI in Life Science Market is projected to grow from about USD 21.58 billion in 2026 to ...
According to MarketsandMarkets, the AI in Life Science Market is projected to grow from about USD 21.58 billion in 2026 to USD 69.34 billion by ...
1d
Collegium Pharmaceutical, Inc.: Collegium Completes Acquisition of AZSTARYS from Corium Therapeutics
Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium's Existing ADHD Portfolio - - Extends Collegium's Long-Term Revenue Outlook; AZSTARYS has Expected ...
The global Specialty Chemicals Market is expected to witness substantial growth, projected to reach US$ 1059 billion by 2030 ...
Formulation development serves as a vital bridge between a drug substance and a drug product that will remain stable and ...
Uncountable, a software company that develops AI platforms for end-to-end product development, today announced it has signed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results